In ALS, the delivery of glial cell-derived neurotrophic factor (GDNF) or brain derived neurotrophic factor (BDNF) to the spinal cord is improved by conjugation with TTC after intramuscular administration (Ciriza et al., 2008; Calvo et al., 2011). Here, GDNF is linked to amyotrophic lateral sclerosis.